This sensitivity for BRD4 inhibition seems to stem from a sort of epigenetic addiction to superenhancers characteristic of leukaemia and appears to be a more general feature of cancers, independent from the underlying genetic anomaly [7]. Here, BRD4 is linked to cancer.